Food & Drug Administration

Breast Cancer

New Breast Cancer Treatment Awaiting FDA Approval

The new drug, called Perjeta, is designed to shrink breast cancer tumors before surgery in the 20 percent of women with tumors fueled by the HER2 positive protein.



Get every new post delivered to your Inbox.

Join 4,825 other followers